Holly M. KoncickiDivision of Nephrology, Icahn School of Medicine at Mount Sinai, Brookdale Department of Geriatrics and Palliative Medicine, New York, New York
United States Renal Data System: USRDS Annual Data Report: Epidemiology of kidney disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2022.
United States Renal Data System: USRDS Annual Data Report: Epidemiology of kidney disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2022.)| false
HsuCM, MuradH, NeuendorfK, GaoT, ScholdJD, SaeedF: Outcomes of palliative care consultation in patients with ESRD who received cardiopulmonary resuscitation. Clin Nephrol96: 22–28, 202110.5414/CN110096PubMed
HsuCM, MuradH, NeuendorfK, GaoT, ScholdJD, SaeedF: Outcomes of palliative care consultation in patients with ESRD who received cardiopulmonary resuscitation. Clin Nephrol 96: 22–28, 202110.5414/CN110096PubMed)| false
WachtermanMW, CorneauEE, O’HareAM, KeatingNL, MorV: Association of hospice payer with concurrent receipt of hospice and dialysis among US veterans with end-stage kidney disease: A retrospective analysis of a national cohortJAMA Health Forum3: e223708, 202210.1001/jamahealthforum.2022.3708PubMed
WachtermanMW, CorneauEE, O’HareAM, KeatingNL, MorV: Association of hospice payer with concurrent receipt of hospice and dialysis among US veterans with end-stage kidney disease: A retrospective analysis of a national cohortJAMA Health Forum 3: e223708, 202210.1001/jamahealthforum.2022.3708PubMed)| false
CacheiraE, MateusC, CalcaR, et al: Letter to the editor: End of life and peritoneal dialysis maintenance: Is it possible?J Palliat Med25: 1758–1759, 202210.1089/jpm.2022.0410
CacheiraE, MateusC, CalcaR, et al: Letter to the editor: End of life and peritoneal dialysis maintenance: Is it possible?J Palliat Med 25: 1758–1759, 202210.1089/jpm.2022.0410)| false
GallagherDM, ZhaoC, GoldsteinBA: A readmission risk model for hospitalized patients receiving dialysis: Evaluation of predictive performance. Kidney Med4: 100507, 202210.1016/j.xkme.2022.100507PubMed
GallagherDM, ZhaoC, GoldsteinBA: A readmission risk model for hospitalized patients receiving dialysis: Evaluation of predictive performance. Kidney Med 4: 100507, 202210.1016/j.xkme.2022.100507PubMed)| false
PlantingaLC, KhakhariaA, HogeC, VandenbergAE, LeaJP, MasudT, et al: Effectiveness of a web-based provider communications platform in reducing hospital readmissions among patients receiving dialysis: A pilot pre-post study. Kidney Med4: 100511, 202210.1016/j.xkme.2022.100511PubMed
PlantingaLC, KhakhariaA, HogeC, VandenbergAE, LeaJP, MasudT, et al: Effectiveness of a web-based provider communications platform in reducing hospital readmissions among patients receiving dialysis: A pilot pre-post study. Kidney Med 4: 100511, 202210.1016/j.xkme.2022.100511PubMed)| false
CoscasR, PetricaN, MassyZ, JayetJ, De LaunayJ: Readmissions following arteriovenous access creation for haemodialysis in a French national database. Eur J Vasc Endovasc Surg64: 703–710, 202210.1016/j.ejvs.2022.08.013PubMed
CoscasR, PetricaN, MassyZ, JayetJ, De LaunayJ: Readmissions following arteriovenous access creation for haemodialysis in a French national database. Eur J Vasc Endovasc Surg 64: 703–710, 202210.1016/j.ejvs.2022.08.013PubMed)| false
ElgendyA, AbdelsalamAI, MansourM, NassarMK: Can residual kidney function affect quality of life and cognitive function in hemodialysis patients?BMC Nephrol23: 263, 202210.1186/s12882-022-02892-7PubMed
ElgendyA, AbdelsalamAI, MansourM, NassarMK: Can residual kidney function affect quality of life and cognitive function in hemodialysis patients?BMC Nephrol 23: 263, 202210.1186/s12882-022-02892-7PubMed)| false
MuraliKM, MullanJ, RoodenrysS, Cheikh HassanHI, LonerganM: Changes in measures of cognitive function in patients with end-stage kidney disease on dialysis and the effect of dialysis vintage: A longitudinal cohort study. PLoS One16: e0252237, 202110.1371/journal.pone.0252237PubMed
MuraliKM, MullanJ, RoodenrysS, Cheikh HassanHI, LonerganM: Changes in measures of cognitive function in patients with end-stage kidney disease on dialysis and the effect of dialysis vintage: A longitudinal cohort study. PLoS One 16: e0252237, 202110.1371/journal.pone.0252237PubMed)| false
YangY, DaJ, LiQ, LongY, YuanJ, ZhaY: The impact of malnutrition, inflammation on cognitive impairment in hemodialysis patients: A multicenter study. Kidney Blood Press Res 47: 711–721, 202210.1159/000527453PubMed)| false
WangY, ZhangHX, WangYC, SongSH, JinXQ, TianN, et al: A survey of cognitive function in peritoneal dialysis patients. Ther Apher Dial26: 822–826, 202210.1111/1744-9987.13777PubMed
WangY, ZhangHX, WangYC, SongSH, JinXQ, TianN, et al: A survey of cognitive function in peritoneal dialysis patients. Ther Apher Dial 26: 822–826, 202210.1111/1744-9987.13777PubMed)| false
LuoCM, HsiehMY, ChengCH, ChenCH, LiaoMT, ChuangSY, et al: Association of frailty with thrombosis of hemodialysis vascular access: A prospective Taiwanese cohort study. Am J Kidney Dis80: 353–363.e1, 202210.1053/j.ajkd.2021.12.017PubMed
LuoCM, HsiehMY, ChengCH, ChenCH, LiaoMT, ChuangSY, et al: Association of frailty with thrombosis of hemodialysis vascular access: A prospective Taiwanese cohort study. Am J Kidney Dis 80: 353–363.e1, 202210.1053/j.ajkd.2021.12.017PubMed)| false
WooK, GascueL, NorrisK, LinE: Patient frailty and functional use of hemodialysis vascular access: A retrospective study of the US Renal Data System. Am J Kidney Dis80: 30–45, 202210.1053/j.ajkd.2021.10.011PubMed
WooK, GascueL, NorrisK, LinE: Patient frailty and functional use of hemodialysis vascular access: A retrospective study of the US Renal Data System. Am J Kidney Dis 80: 30–45, 202210.1053/j.ajkd.2021.10.011PubMed)| false
de RooijENM, MeulemanY, de FijterJW, JagerKJ, ChesnayeNC, EvansM, et al; EQUAL study investigators: Symptom burden before and after dialysis initiation in older patients. Clin J Am Soc Nephrol17: 1719–1729, 202210.2215/CJN.09190822PubMed
de RooijENM, MeulemanY, de FijterJW, JagerKJ, ChesnayeNC, EvansM, et al; EQUAL study investigators: Symptom burden before and after dialysis initiation in older patients. Clin J Am Soc Nephrol 17: 1719–1729, 202210.2215/CJN.09190822PubMed)| false
de RooijENM, MeulemanY, de FijterJW, Le CessieS, JagerKJ, ChesnayeNC, et al; EQUAL study investigators: Quality of life before and after the start of dialysis in older patients. Clin J Am Soc Nephrol17: 1159–1167, 202210.2215/CJN.16371221PubMed
de RooijENM, MeulemanY, de FijterJW, Le CessieS, JagerKJ, ChesnayeNC, et al; EQUAL study investigators: Quality of life before and after the start of dialysis in older patients. Clin J Am Soc Nephrol 17: 1159–1167, 202210.2215/CJN.16371221PubMed)| false
TopfJ, WooldridgeT, McCaffertyK, SchömigM, CsikyB, ZwiechR, et al: Efficacy of difelikefalin for treatment of moderate to severe pruritus in hemodialysis patients: Pooled analysis of KALM-1 and KALM-2 phase 3 studies. Kidney Med4: 100512, 202210.1016/j.xkme.2022.100512PubMed
TopfJ, WooldridgeT, McCaffertyK, SchömigM, CsikyB, ZwiechR, et al: Efficacy of difelikefalin for treatment of moderate to severe pruritus in hemodialysis patients: Pooled analysis of KALM-1 and KALM-2 phase 3 studies. Kidney Med 4: 100512, 202210.1016/j.xkme.2022.100512PubMed)| false
FishbaneS, WenW, MuneraC, LinR, BagalS, McCaffertyK, et al: Safety and tolerability of difelikefalin for the treatment of moderate to severe pruritus in hemodialysis patients: Pooled analysis from the phase 3 clinical trial program. Kidney Med4: 100513, 202210.1016/j.xkme.2022.100513PubMed
FishbaneS, WenW, MuneraC, LinR, BagalS, McCaffertyK, et al: Safety and tolerability of difelikefalin for the treatment of moderate to severe pruritus in hemodialysis patients: Pooled analysis from the phase 3 clinical trial program. Kidney Med 4: 100513, 202210.1016/j.xkme.2022.100513PubMed)| false
OestreichT, SayreG, O’HareAM, CurtisJR, WongSPY: Perspectives on conservative care in advanced kidney disease: A qualitative study of US patients and family members. Am J Kidney Dis77: 355–364.e1, 202110.1053/j.ajkd.2020.07.026PubMed
OestreichT, SayreG, O’HareAM, CurtisJR, WongSPY: Perspectives on conservative care in advanced kidney disease: A qualitative study of US patients and family members. Am J Kidney Dis 77: 355–364.e1, 202110.1053/j.ajkd.2020.07.026PubMed)| false
SobelsE, BestM, ChadbanS, PaisR: End stage kidney disease patient experiences of renal supportive care in an Australian teaching hospital—A qualitative study. J Pain Symptom Manage63: 737–746, 202210.1016/j.jpainsymman.2021.12.024PubMed
SobelsE, BestM, ChadbanS, PaisR: End stage kidney disease patient experiences of renal supportive care in an Australian teaching hospital—A qualitative study. J Pain Symptom Manage 63: 737–746, 202210.1016/j.jpainsymman.2021.12.024PubMed)| false
RussellJSC, OliverioA, PaulusA: Barriers to conservative management conversations: Perceptions of nephrologists and fellows-in-training. J Palliat Med 24: 1497–1504, 202110.1089/jpm.2020.0690PubMed)| false
HongYA, ChungS, ParkWY, BaeEJ, YangJW, ShinDH, et al; Committee on Ethical Issues of the Korean Society of Nephrology: Nephrologists’ perspectives on decision making about life-sustaining treatment and palliative care at the end of life: A questionnaire survey in Korea. J Palliat Med24: 527–535, 202110.1089/jpm.2020.024PubMed
HongYA, ChungS, ParkWY, BaeEJ, YangJW, ShinDH, et al; Committee on Ethical Issues of the Korean Society of Nephrology: Nephrologists’ perspectives on decision making about life-sustaining treatment and palliative care at the end of life: A questionnaire survey in Korea. J Palliat Med 24: 527–535, 202110.1089/jpm.2020.024PubMed)| false
SaeedF, LadwigS, AllenRJ, et al.Racial disparities in health beliefs and advance care planning among patients receiving maintenance dialysis. J Pain Symptom Manage65: 318–325, 202310.1016/j.jpainsymman.2022.12.002
SaeedF, LadwigS, AllenRJ, et al.Racial disparities in health beliefs and advance care planning among patients receiving maintenance dialysis. J Pain Symptom Manage 65: 318–325, 202310.1016/j.jpainsymman.2022.12.002)| false
HaugK, BuffingtonA, ZelenskiA, HanlonBM, StalterL, KwekkeboomKL, et al: Best case/worst case: Protocol for a multisite randomised clinical trial of a scenario planning intervention for patients with kidney failure. BMJ Open12: e067258, 202210.1136/bmjopen-2022-06725PubMed
HaugK, BuffingtonA, ZelenskiA, HanlonBM, StalterL, KwekkeboomKL, et al: Best case/worst case: Protocol for a multisite randomised clinical trial of a scenario planning intervention for patients with kidney failure. BMJ Open 12: e067258, 202210.1136/bmjopen-2022-06725PubMed)| false
WuW, GremelGW, HeK, MessanaJM, SenA, SegalJH, et al: The impact of COVID-19 on postdischarge outcomes for dialysis patients in the United States: Evidence from medicare claims data. Kidney3603: 1047–1056, 202210.34067/KID.0000242022PubMed
WuW, GremelGW, HeK, MessanaJM, SenA, SegalJH, et al: The impact of COVID-19 on postdischarge outcomes for dialysis patients in the United States: Evidence from medicare claims data. Kidney360 3: 1047–1056, 202210.34067/KID.0000242022PubMed)| false
HemmelderMH, NoordzijM, VartP, HilbrandsLB, JagerKJ, AbrahamsAC, et al; ERACODA Collaborators: Recovery of dialysis patients with COVID-19: Health outcomes 3 months after diagnosis in ERACODA. Nephrol Dial Transplant37: 1140–1151, 202210.1093/ndt/gfac008PubMed
ZakiKE, HuangCW, ZhouH, ChungJ, SelevanDC, RutkowskiMP, et al: Comparison of safety and outcomes related to remdesivir treatment among dialysis patients hospitalized with COVID-19. Clin Kidney J15: 2056–2062, 202210.1093/ckj/sfac185PubMed
ZakiKE, HuangCW, ZhouH, ChungJ, SelevanDC, RutkowskiMP, et al: Comparison of safety and outcomes related to remdesivir treatment among dialysis patients hospitalized with COVID-19. Clin Kidney J 15: 2056–2062, 202210.1093/ckj/sfac185PubMed)| false